Elanco Animal Health

Chief Inventor, Drug Discovery & Innovation

Elanco Animal Health • $180K — $220K *
Pharmaceuticals & Biotech
11 - 15 years of experience
Job Overview by Ladders

Qualifications

  • PhD and/or DVM in life sciences; dual degree preferred.
  • 15+ years of experience in drug discovery and invention within pharma or biotech.
  • Recognized global expert with a portfolio of impactful patents.
  • Deep expertise in high-barrier biology and modality engineering.
  • Ability to drive impact independently as a self-directed individual contributor.
  • Strategic vision to foresee market needs a decade ahead.

Responsibilities

  • Pioneer novel scientific breakthroughs for veterinary medicine.
  • Explore and identify revolutionary drug targets and pathways.
  • Secure foundational IP for innovative drug candidates.
  • Solve complex biological problems impacting drug delivery.
  • Challenge existing programs scientifically to push boundaries.
  • Architect the therapeutic pipeline for the year 2030.
  • Collaborate with R&D to develop and optimize novel platforms.

Benefits

  • Relocation packages for new hires.
  • Mid-summer and year-end two weeklong shutdowns.
  • 8-week parental leave policy.
  • Diverse Employee Resource Groups for community building.
  • Annual bonus opportunities based on performance.
  • Flexible work arrangements to promote work-life balance.
  • 401K matching up to 6% for retirement savings.
Full Job Description

Job Description: Chief Inventor, Drug Discovery & Innovation


As Elanco architects the future of animal health, the Senior Advisor, Chief Inventor 6 Drug Discovery & Innovation serves as a senior scientific advisor and primary engine for de novo breakthroughs. This top-tier scientific leadership role within the Mechanistic and Translational Biology innovation engine combines enterprise-level scientific influence with a clear mandate to identify, invent, and advance novel concepts that do not yet exist in the current market. This role is tasked with decoupling discovery from luck by institutionalizing a proactive innovation engine. The Inventor is responsible for securing the foundational IP for high-value assets and defining Elancos therapeutic frontier beyond 2030.


Your Responsibilities

1. Pioneer De Novo Breakthroughs

  • Innovation "White Space" Exploration: Proactively identify and explore revolutionary external and internal scientific opportunities that are 10 years away from current market solutions. This comprehensive scope includes:Novel Drug Targets & Pathways: Architecting first-in-class biological hypotheses and identifying untapped disease mechanisms.Innovative Drug Delivery Platforms: Solving high-barrier challenges such as oral delivery of large molecules and targeted intracellular delivery.Next-Generation Drug Modalities: Pioneering new therapeutic categories and molecular formats (e.g., protein degraders, advanced biologics).Advanced Target ID & Discovery Platforms: Building proprietary systems and methodologies to institutionalize a proactive discovery engine.
  • Beyond "Me-Too" Science: Move past the adaptation of proven human health targets to engineer original, proprietary veterinary-specific biological hypotheses that dont yet exist in any market.
  • Foundational IP: Secure and engineer proprietary Intellectual Property across all innovative domains by navigating around legacy patents to ensure Elanco owns the foundational IP for every high-value candidate.

2. Solve High-Barrier Biology & Platform Invention

  • Complex Problem Solving: Tackle the most challenging technical hurdles in discovery, such as oral delivery of large molecules or intracellular targeting.
  • Scientific Challenger: Act as an internal scientific challenger to existing programs, ensuring Elanco pushes the boundaries of what is biologically possible.
  • Biological Firsts: Establish "biological firsts" that set the standard for the animal health industry.

3. Architect the 2030 Frontier

  • Pipeline Refill: Ensure a constant state of high-value pipeline refill by architecting new therapeutic categories.
  • Strategic Modality Optimization: Optimize known modalities while simultaneously inventing novel delivery platforms and proprietary platform builds.
  • Innovation Strategy: Transform discovery into a proactive, strategic process that defines the market rather than following it.

4. Cross-Functional Partnership & R&D Integration

  • Novel Platform Partnership: Collaborate extensively across R&D to drive the development of novel therapeutic platforms. This includes partnering with:Technical Development: Ensuring the manufacturability and technical feasibility of pioneering modalities from early invention.Small Molecule & Large Molecule Teams: Working synchronously with modality-specific experts to integrate novel platforms (e.g., specialized delivery systems or molecular formats) into the discovery engine.
  • Discovery Pillar Collaboration: Partner deeply across the Mechanistic and Translational Biology leadership pillars to transition revolutionary concepts into the pipeline. This includes:Working with Structural Biology to refine molecular drug design and delivery viability.Aligning with Target Intelligence & Discovery to validate novel pathways and transition from "white space" exploration to formal target assessment.Collaborating with Translational Biology to ensure de novo concepts are anchored in clinical unmet needs and species-specific physiology.
  • Broader R&D Integration: Serve as a strategic scientific advisor across the wider R&D ecosystem, partnering with Global Clinical Stewardship (GCS), External Innovation (EI), and CMC/Manufacturing to ensure the scalability and technical feasibility of next-generation modalities.
  • Scientific Challenger & Mentor: Act as a high-level scientific challenger during R&D program reviews, pushing the organization to maintain the highest standards of scientific rigor. Provide peer-to-peer mentorship to high-potential scientists across the Discovery organization.
  • Special Strategic Projects: Lead special high-impact projects that require deep scientific expertise and visionary drug design.

What You Need to Succeed (minimum qualifications)

  • Education: PhD and/or DVM in a life sciences field (e.g., Molecular Biology, Biochemistry, Bioengineering, or related discipline). A dual degree is highly preferred.
  • Experience: 15+ years of distinguished experience in drug discovery and invention. A proven track record of moving from concept to successful candidate in the pharmaceutical or biotech industry.
  • Scientific Pedigree: Recognized as a global expert in their field, with a documented portfolio of high-impact patents that have demonstrably moved the field forward. Must possess a track record of translating original concepts into protected, proprietary assets.
  • Technical Mastery: Deep expertise in high-barrier biology, modality engineering, and predictive biological modeling.
  • Individual Contributor Excellence: Ability to drive significant organizational impact without the need for a formal team structure; must be self-directed and capable of leading through influence and scientific authority.
  • Strategic Vision: An innovation-focused mindset with the ability to foresee market needs a decade in advance.



Additional Information

Department: Mechanistic and Translational Biology
Role Type: Dedicated Individual Contributor (R5+ Level)
Location: Based in US or EU (Hybrid)
Travel: Up to 25% travel required


Additional Job Description

Dont meet every single requirement? Studies have shown underrepresented groups are less likely to apply to jobs unless they meet every single qualification. At Elanco we are dedicated to building a diverse and inclusive work environment. If you think you might be a good fit for a role but dont necessarily meet every requirement, we encourage you to apply. You may be the right candidate for this role or other roles!


Elanco Benefits and Perks:

We offer a comprehensive benefits package focusing on financial, physical, and mental well-being while encouraging our employees to pursue our purpose! Some highlights include:

  • Multiple relocation packages
  • Two weeklong shutdowns (mid-summer and year-end) in the US (in addition to PTO)
  • 8-week parental leave
  • 9 Employee Resource Groups
  • Annual bonus offering
  • Flexible work arrangements
  • Up to 6% 401K matching

About Elanco Animal Health

Elanco Animal Health is an American pharmaceutical company that develops and produces products for animal health. The company was founded in 1954 and is headquartered in Greenfield, Indiana. Elanco produces a wide range of products for both livestock and pets, including vaccines, antibiotics, and parasiticides. The company operates in more than 90 countries and has a global workforce of over 5,500 employees. Elanco was spun off from Eli Lilly and Company in 2018 and became a publicly traded company in September of that year. The company is listed on the New York Stock Exchange under the ticker symbol ELAN.
Learn more about Elanco Animal Health
Size
9,000 employees
Market Cap
$5.3 billion
Industry
Net Income
-$560 million
5 Year Trend
+10.3%
Revenue
$3.2 billion
NASDAQ

Similar Jobs

More Jobs at Elanco Animal Health

More Pharmaceuticals & Biotech Jobs

Find similar Chief Inventor, Drug Discovery & Innovation jobs: